GKOS vs ZBH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
GKOS · Glaukos$224.41 ▲ 2.01%
ZBH · Zimmer Biomet Holdings$105.59 ▼ 1.18%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- GKOS +154.0%
- ZBH +20.3%
Head to head
| Metric | GKOS | ZBH |
|---|---|---|
| Price | $224.41 | $105.59 |
| Change today | ▲ 2.01% | ▼ 1.18% |
| Market cap | $13.28B | $19.98B |
| Return, 3 months | +23.7% | +8.3% |
| Return, year to date | +98.8% | +18.4% |
| Return, 1 year | +167.6% | +20.6% |
| P/E (TTM) | -76.1 | 26.7 |
| P/B | 18.5 | 1.6 |
| P/E percentile vs own 5y | 2nd | 33rd |
| Dividend yield | – | 0.91% |
| Revenue growth (YoY, latest qtr) | +58.0% | +4.8% |
| Net profit growth (YoY) | +112.4% | +30.1% |
| Gross margin | 64.8% | 69.9% |
| Operating margin | -25.3% | 16.3% |
| Net margin | -24.6% | 9.5% |
| Return on equity | -22.8% | 6.4% |
| Analyst target vs. price | +5.8% | +1.9% |
| Analyst buy share | 100% | 33% |
| RSI (14) | 64 | 64 |
| 30-day volatility | 98.5% | 46.8% |
| Max drawdown, 1 year | -28.4% | -22.5% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ZBH is the largest of the group by market value.
- GKOS has returned the most over the past year.
- GKOS carries the lowest trailing P/E.
- GKOS is growing revenue fastest.
- ZBH keeps the most profit per dollar of sales.
- ZBH has been the calmest stock over the last 30 days.